The 340B Drug Pricing Program (“340B Program”) space continues to be a hive of activity. While 340B stakeholders continue to litigate ongoing manufacturer contract pharmacy restrictions, states ...
States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to get out from under the budgetary squeeze that took them by ...
The American Hospital Association and several large hospital systems have filed a lawsuit seeking to halt an upcoming pilot ...
Competing policy efforts to lower drug prices could muddy the waters of drug pricing and leave patients unable to afford ...
Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, ...
One reason libertarians don’t trust the government is because so many well-intentioned government programs end up either making things worse for the supposed beneficiaries, enriching wealthy and ...
Oklahoma will be the first state to experiment with charging drug companies if their medicines don’t deliver the results they promised. The Oklahoma Health Care Authority announced Thursday that it ...
There’s no question that the budget reconciliation process is one of the most politically complex tasks Congress undertakes. But the pressure to pass a package cannot justify bad policy—especially ...
States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to get out from under the budgetary squeeze that took them by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback